EUVIMEDEUVIMED entdecken
Crossref

Empowering Minds: A Pilot Study to Assess Feasibility of ADAPT‐SCD to Enhance Cognitive Function in Adolescents and Young Adults With Sickle Cell Disease

Grace Hurley, Elizabeth Skidmore, Taniya Varughese, Abigail Picinich, Nai Qashou, Odaro Adu, Allison A King iD

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Grace Hurley und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Cognition, Executive Function. Die Arbeit nennt 44 Literaturangaben. Gefördert von: HRSA HHS, NIH HHS, Health Resources and Services Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Executive functioning (EF) deficits are a well‐documented complication of sickle cell disease (SCD), yet no standard intervention exists to address this issue. Adapting Daily Activity Performance Through Strategy Training (ADAPT) is a metacognitive strategy training protocol designed to enhance self‐assessment and strategic problem‐solving, showing potential to mitigate EF deficits in individuals with SCD. Procedure Adolescents and young adults (AYA) aged 16–25 years with a documented SCD diagnosis were recruited. Baseline assessments of depression, self‐awareness, and EF were conducted. Participants completed an adapted version of ADAPT, known as ADAPT‐SCD, consisting of 10–14 sessions delivered either in person or via telehealth. Follow‐up assessments were conducted immediately post‐program and 6 months later. Feasibility was defined as 50% of approached AYA consenting and 10 participants completing at least 10 sessions. Acceptability was determined through participant responses in post‐program interviews and surveys. A secondary aim was to examine the changes in EF and depression scores.

Results

Feasibility of ADAPT‐SCD was partially supported, with 38% (19/50) of approached AYA enrolling, and 10 participants completing the required 10 sessions. Acceptability was supported through positive participant feedback on post‐program surveys and interviews. While most changes in EF and depression measures were not clinically significant, the List Sorting Working Memory subtest of the National Institutes of Health Toolbox‐Cognitive Battery showed a significant improvement.

Conclusions

ADAPT‐SCD demonstrated strong acceptability and partial feasibility. However, its impact on EF and depression outcomes warrants further investigation to establish clinical significance and inform future interventions for SCD‐related cognitive challenges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellCognitionExecutive FunctionHumansAdolescentPilot ProjectsMaleFemaleYoung AdultAdultFeasibility StudiesFollow-Up StudiesDepression

Stichwörter der Autor:innen

adolescentscognitionexecutive functionsickle cell disease

Autor:innen und Institutionen

  • Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Occupational Therapy, School of Health and Rehabilitation Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Program in Occupational Therapy, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Education, Washington University School of Medicine, St. Louis, Missouri, USA.

ORCID-Profile: Allison A King

Förderung

  • HRSA HHS
  • NIH HHS
  • Health Resources and Services Administration
  • National Institutes of Health

Zitieren

APA

Hurley, G., Skidmore, E., Varughese, T., Picinich, A., Qashou, N., Adu, O., & King, A. A. (2025). Empowering Minds: A Pilot Study to Assess Feasibility of ADAPT‐SCD to Enhance Cognitive Function in Adolescents and Young Adults With Sickle Cell Disease. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31942

Vancouver

Hurley G, Skidmore E, Varughese T, Picinich A, Qashou N, Adu O, et al. Empowering Minds: A Pilot Study to Assess Feasibility of ADAPT‐SCD to Enhance Cognitive Function in Adolescents and Young Adults With Sickle Cell Disease. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31942

BibTeX
@article{Hurley2025,
  author = {Hurley, Grace and Skidmore, Elizabeth and Varughese, Taniya and Picinich, Abigail and Qashou, Nai and Adu, Odaro and King, Allison A},
  title = {Empowering Minds: A Pilot Study to Assess Feasibility of ADAPT‐SCD to Enhance Cognitive Function in Adolescents and Young Adults With Sickle Cell Disease},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31942}
}
Kostenlos starten →